CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

ACETAMINOPHEN ASPIRIN AND CAFFEINE

Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg· ingredient aspirinOther agents for local oral treatment· ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.06716
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other aspirin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
adult low dose aspirin$0.01438−$0.05280
Aspirin$0.01601−$0.05120
Aspirin$0.02233−$0.04480
Adult Chewable Aspirin$0.02595−$0.04120
AeroTab Pain Reliever$0.04346−$0.02370
Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg$0.57275+$0.50560
butalbital, aspirin, and caffeine$0.97831+$0.91120
Ascomp with Codeine$1.09+$1.02

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.